Public Health

Ministry of Health incorporates new test for donor screening SUS

Test detects agents capable of developing diseases such as AIDS and hepatitis C for shorter periods than the current

On the eve of World Blood Donor celebrated tomorrow (14), the Ministry of Health incorporated nucleic acid testing (Nat) serological screening of the donor of the Unified Health System (SUS). The measure was published in the Official Gazette and shall assert in 180 days. The test detects chemical agents capable of developing diseases, particularly the HIV virus and hepatitis C, for shorter periods than conventional tests.

The blood received from donors undergoes tests. Tests are related to infectious diseases able to be transmitted via transfusion. This step aims to ensure the safety of the patient who will receive the blood. The goal of the ministry is to analyze up to 3.5 million units of blood annually, covering the full Brazilian public blood.

According to the president of the Brazilian Association of Hematology, Hematology and Cell Therapy, Carmino Antonio Souza, the test adopted in Western Europe, North America and Asia shortens the time for detection of viruses in donated blood for HIV and 22 for seven days, hepatitis C, from 70 to 11 days in average. "One of the biggest challenges of transfusion medicine worldwide is increasingly shorten the window period, during which virus remains undetectable on an individual," he said. The association celebrated the incorporation of the SUS test, but charges the Ministry of Health to test Nat mandatory across the country, including health supplement (plans and private health insurance companies).

The Program Manager for Diagnostics Reagents Biomanguinhos, Antonio Gomes Ferreira Pinto explained that the Brazilian Nat, produced since 2010, is in constant improvement. Our kit has identified more than ten windows immune [bags of blood contaminated with the AIDS virus or hepatitis C] 2.5 million units of blood screened. It is a very robust data, which shows that the Brazilian Nat fulfills the role which they propose to contribute and expand transfusion safety in Brazil, he said. The manager reported that currently Biomanguinhos Nat Brazilian detects HIV and hepatitis C. The hepatitis B virus and dengue will test the new targets.